Black Rock Inc. Cytek Biosciences, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 17,070,422 shares of CTKB stock, worth $108 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,070,422
Previous 17,425,971
2.04%
Holding current value
$108 Million
Previous $117 Million
18.54%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding CTKB
# of Institutions
134Shares Held
71.7MCall Options Held
400Put Options Held
0-
Vanguard Group Inc Valley Forge, PA11.8MShares$74.4 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD9.49MShares$60 Million1.15% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$42.1 Million0.85% of portfolio
-
State Street Corp Boston, MA4.17MShares$26.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.67MShares$16.9 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $851M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...